Neuroprotection of osthole against cerebral ischemia/reperfusion injury through an anti-apoptotic pathway in rats

Biological and Pharmaceutical Bulletin

Volumn 39, Issue 3, 2016, Pages 336-342

  Li, Kang ^a   Ding, Dun ^a   Zhang, Ming ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Apoptosis; Cerebral; Ischemia; Osthole; Reperfusion

Indexed keywords

CASPASE 3; OSTHOLE; PROTEIN BAX; PROTEIN BCL 2; BAX PROTEIN, RAT; COUMARIN DERIVATIVE; NEUROPROTECTIVE AGENT; WATER;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN WATER; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVATION; HISTOPATHOLOGY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PROTEIN CLEAVAGE; RAT; REPERFUSION INJURY; TUNEL ASSAY; ANIMAL; BRAIN; DNA FRAGMENTATION; DRUG EFFECTS; INFARCTION, MIDDLE CEREBRAL ARTERY; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BRAIN; CASPASE 3; COUMARINS; DNA FRAGMENTATION; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; NEUROPROTECTIVE AGENTS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; WATER;

EID: 84962505078     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b15-00699     Document Type: Article

References (30)

1. Chen YL, Wu XM, Yu SS, Lin XM, Wu JX, Li L, Zhao J, Zhao Y. Neuroprotection of Tanshinone IIA against cerebral ischemia/reperfusion injury through inhibition of macrophage migration inhibitory factor in rats. PLoS ONE, 7, e 40165 (2012).
2. Sun YX, Liu T, Dai XL, Zheng QX, Hui BD, Jiang ZF. Treatment with lutein provides neuroprotection in mice subjected to transient cerebral ischemia. J. Asian Nat. Prod. Res., 16, 1084-1093 (2014).
3. Banerjee S, Williamson D, Habib N, Gordon M, Chataway J. Human stem cell therapy in ischaemic stroke: a review. Age Ageing, 40, 7-13 (2011).
4. Ferrer I. Apoptosis: future targets for neuroprotective strategies. Cerebrovasc. Dis., 21(Suppl. 2), 9-20 (2006).
5. Li M, Zhang X, Cui L, Yang R, Wang L, Liu L, Du W. The neuroprotection of oxymatrine in cerebral ischemia/reperfusion is related to nuclear factor erythroid 2-related factor 2 (nrf2)-mediated antioxidant response: role of nrf2 and hemeoxygenase-1 expression. Biol. Pharm. Bull., 34, 595-601 (2011).
6. Qi J, Hong ZY, Xin H, Zhu YZ. Neuroprotective effects of leonurine on ischemia/reperfusion-induced mitochondrial dysfunctions in rat cerebral cortex. Biol. Pharm. Bull., 33, 1958-1964 (2010).
7. Back T. Pathophysiology of the ischemic penumbra-revision of a concept. Cell. Mol. Neurobiol., 18, 621-638 (1998).
8. Teng CM, Lin CH, Ko FN, Wu TS, Huang TF. The relaxant action of osthole isolated from Angelica pubescens in guinea-pig trachea. Naunyn Schmiedebergs Arch. Pharmacol., 349, 202-208 (1994).
9. Chen J, Chiou WF, Chen CC, Chen CF. Effect of the plant-extract osthole on the relaxation of rabbit corpus cavernosum tissue in vitro. J. Urol., 163, 1975-1980 (2000).
10. Zheng Y, Lu M, Ma L, Zhang S, Qiu M, Wang Y. Osthole ameliorates renal ischemia-reperfusion injury in rats. J. Surg. Res., 183, 347-354 (2013).
11. Okamoto T, Kawasaki T, Hino O. Osthole prevents anti-Fas antibody-induced hepatitis in mice by affecting the caspase-3-mediated apoptotic pathway. Biochem. Pharmacol., 65, 677-681 (2003).
12. Liu WB, Zhou J, Qu Y, Li X, Lu CT, Xie KL, Sun XL, Fei Z. Neuroprotective effect of osthole on MPP+-induced cytotoxicity in PC12 cells via inhibition of mitochondrial dysfunction and ROS production. Neurochem. Int., 57, 206-215 (2010).
13. Mao X, Yin W, Liu M, Ye M, Liu P, Liu J, Lian Q, Xu S, Pi R. Osthole, a natural coumarin, improves neurobehavioral functions and reduces infarct volume and matrix metalloproteinase-9 activity after transient focal cerebral ischemia in rats. Brain Res., 1385, 275-280 (2 011).
14. Zhao J, Yu SS, Zheng W, Feng G, Luo G, Wang L, Zhao Y. Curcumin improves outcomes and attenuates focal cerebral ischemic injury via antiapoptotic mechanisms in rats. Neurochem. Res., 35, 374-379 (2010).
15. Wang W, Xu J, Li L, Wang P, Ji X, Ai H, Zhang L, Li L. Neuroprotective effect of morroniside on focal cerebral ischemia in rats. Brain Res. Bull., 83, 196-201 (2010).
16. Chao X, Zhou J, Chen T, Liu W, Dong W, Qu Y, Jiang X, Ji X, Zhen H, Fei Z. Neuroprotective effect of osthole against acute ischemic stroke on middle cerebral ischemia occlusion in rats. Brain Res., 1363, 206-211 (2010).
17. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke, 20, 84-91 (1989).
18. Hatashita S, Hoff JT, Salamat SM. Ischemic brain edema and the osmotic gradient between blood and brain. J. Cereb. Blood Flow Metab., 8, 552-559 (1988).
19. Yu SJ, Kim JR, Lee CK, Han JE, Lee JH, Kim HS, Hong JH, Kang SG. Gastrodia elata blume and an active component, p-hydroxybenzyl alcohol reduce focal ischemic brain injury through antioxidant related gene expressions. Biol. Pharm. Bull., 28, 1016-1020 (2005).
20. Zhou J, Zeng P, Cheng ZH, Liu J, Wang FQ, Qian RJ. Application of hollow fiber liquid phase microextraction coupled with highperformance liquid chromatography for the study of the osthole pharmacokinetics in cerebral ischemia hypoperfusion rat plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 879, 2304-2310 (2 011).
21. Appelboom G, Strozyk D, Meyers PM, Higashida RT. Current recommendations for endovascular interventions in the treatment of ischemic stroke. Curr. Atheroscler. Rep., 12, 244-250 (2010).
22. Guo C, Tong L, Xi M, Yang H, Dong H, Wen A. Neuroprotective effect of calycosin on cerebral ischemia and reperfusion injury in rats. J. Ethnopharmacol., 144, 768-774 (2012).
23. Hsiao G, Fong TH, Tzu NH, Lin KH, Chou DS, Sheu JR. A potent antioxidant, lycopene, affords neuroprotection against microglia activation and focal cerebral ischemia in rats. In Vivo, 18, 351-356 (2004).
24. Ames A 3rd, Wright RL, Kowada M, Thurston JM, Majno G. Cerebral ischemia. II. The no-reflow phenomenon. Am. J. Pathol., 52, 437-453 (1968).
25. Jung YS, Oh AY, Park HP, Hwang GW, Lim YJ, Jeon YT. Postischemic administration of pravastatin reduces neuronal injury by inhibiting Bax protein expression after transient forebrain ischemia in rats. Neurosci. Lett., 594, 87-92 (2015).
26. Chen D, Tang J, Khatibi NH, Zhu M, Li Y, Wang C, Jiang R, Tu L, Wang S. Treatment with Z-ligustilide, a component of Angelica sinensis, reduces brain injury after a subarachnoid hemorrhage in rats. J. Pharmacol. Exp. Ther., 337, 663-672 (2011).
27. Cory S, Adams JM. The Bcl2 family: regulators of the cellular lifeor-death switch. Nat. Rev. Cancer, 2, 647-656 (2002).
28. McDonnell TJ, Beham A, Sarkiss M, Andersen MM, Lo P. Importance of the Bcl-2 family in cell death regulation. Experientia, 52, 1008-1017 (1996).
29. Miller TM, Moulder KL, Knudson CM, Creedon DJ, Deshmukh M, Korsmeyer SJ, Johnson EM Jr. Bax deletion further orders the cell death pathway in cerebellar granule cells and suggests a caspase-independent pathway to cell death. J. Cell Biol., 139, 205-217 (1997).
30. Prabhakar G, Vona-Davis L, Murray D, Lakhani P, Murray G. Phosphocreatine restores high-energy phosphates in ischemic myocardium: implication for off-pump cardiac revascularization. J. Am. Coll. Surg., 197, 786-791 (2003).